journal article·2026-04

Bi‐Target Nanomodulator for Glioma‐Associated Myeloid Cells Polarization by Inducing Pyroptosis and Regulating Tryptophan Metabolism to Reshape Immunosuppressive Microenvironment of IDH‐Mutant Gliomas

Shiqi Bai, Wanying Li, Na Yin, Yue Cao, Shaopeng Zhang, Ziqian Wang, Donghao Qu, Bin Wang, Yunqian Li, Xinrui Liu, Yanfang Jiang, Yinghui Wang

Advanced Materials· Volume 38· Issue 22
Publisher page

Abstract

ABSTRACT Since 2‐hydroxyglutarate (2‐HG) released from isocitrate dehydrogenase (IDH)‐mutant gliomas results in the strong immunosuppressive tumor microenvironment (TME), the immunotherapy effect is unsatisfactory. In this work, we develop a hybridized cell membrane of glioma‐macrophage cells (GMM) camouflaged bi‐target nanomodulator (LNO@CH/Ca 3 (PO 4 ) 2 , LCC) comprised of LaNiO 3 (LNO) core and Ca 3 (PO 4 ) 2 shell loaded with the aryl hydrocarbon receptor (AhR) antagonist (CH223191, CH), which can synergistically modulate glioma‐associated myeloid cells (GAM) polarization by inducing pyroptosis and regulating tryptophan metabolism to enhance the efficacy of IDH‐mutant gliomas immunotherapy. The hybrid cell membrane endows LCC@GMM with good blood brain barrier (BBB) penetration as well as dual homing ability to tumor cells and GAM. LCC@GMM not only induces pyroptosis in tumor cells by the production of cytotoxic reactive oxygen species (ROS) and the released La 3 + but also regulates tryptophan metabolism in GAM via the released CH, effectively overcoming the immunosuppressive effects of IDH‐mutant gliomas. The bi‐target synergistic regulation of GAM reshapes the immunosuppressive TME of IDH‐mutant gliomas and offers a novel idea for immunotherapy of IDH‐mutant gliomas.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Immune cells in cancer · Glioma Diagnosis and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Rare Earth Resource Utilization Changchun Institute of Applied Chemistry (CIAC) Chinese Academy of Sciences Changchun China

Genetic Diagnosis Center The First Hospital of Jilin University Changchun China

Laboratory of Female Reproductive Health The First Hospital of Jilin University Changchun China

Department of Neurosurgery The First Hospital of Jilin University Changchun China

Department of Colorectal Surgery Harbin Medical University Cancer Hospital Harbin China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Jilin Province

References (39)

Show source-provided references
1. 10.1093/neuonc/noac20710.1093/neuonc/noac207 ↗
2. 10.1007/s13311-022-01313-910.1007/s13311-022-01313-9 ↗
3. 10.1093/neuonc/noz01610.1093/neuonc/noz016 ↗
4. 10.1007/s11910-023-01265-310.1007/s11910-023-01265-3 ↗
5. 10.1016/j.neuron.2019.08.02810.1016/j.neuron.2019.08.028 ↗
6. 10.1038/nrclinonc.2016.21710.1038/nrclinonc.2016.217 ↗
7. 10.1016/j.ccell.2017.07.00610.1016/j.ccell.2017.07.006 ↗
8. 10.1186/s13045-023-01478-610.1186/s13045-023-01478-6 ↗
9. 10.1038/s41565-022-01125-010.1038/s41565-022-01125-0 ↗
10. 10.1016/j.cell.2020.02.00210.1016/j.cell.2020.02.002 ↗
11. 10.1038/nature1551410.1038/nature15514 ↗
12. 10.1039/C9CS00330D10.1039/C9CS00330D ↗
13. 10.1002/adma.20230296110.1002/adma.202302961 ↗
14. 10.1021/acsnano.8b0108610.1021/acsnano.8b01086 ↗
15. 10.1038/nature0861710.1038/nature08617 ↗
16. 10.1038/s43018-021-00201-z10.1038/s43018-021-00201-z ↗
17. 10.1038/onc.2009.10410.1038/onc.2009.104 ↗
18. 10.1038/onc.2015.38710.1038/onc.2015.387 ↗
19. 10.1038/ni.191510.1038/ni.1915 ↗
20. 10.1038/s41590-018-0107-110.1038/s41590-018-0107-1 ↗
21. 10.1002/adfm.20210091910.1002/adfm.202100919 ↗
22. 10.1021/acssuschemeng.0c0375510.1021/acssuschemeng.0c03755 ↗
23. 10.1038/s41467-018-03903-810.1038/s41467-018-03903-8 ↗
24. 10.1038/s41467-019-08657-510.1038/s41467-019-08657-5 ↗
25. 10.1038/s41467-019-14199-710.1038/s41467-019-14199-7 ↗
26. 10.1038/s41467-018-05798-x10.1038/s41467-018-05798-x ↗
27. 10.1016/j.drup.2015.02.00210.1016/j.drup.2015.02.002 ↗
28. Oxidative Stress, Mitochondrial Damage and Neurodegenerative Diseases
29. 10.1016/j.redox.2018.06.01010.1016/j.redox.2018.06.010 ↗
30. 10.1002/adma.20231212410.1002/adma.202312124 ↗
31. 10.1124/mol.105.02183210.1124/mol.105.021832 ↗
32. 10.1016/j.lfs.2016.05.00110.1016/j.lfs.2016.05.001 ↗
33. 10.1002/adfm.20190974510.1002/adfm.201909745 ↗
34. 10.1161/ATVBAHA.120.31515110.1161/ATVBAHA.120.315151 ↗
35. 10.1038/s41571-024-00859-110.1038/s41571-024-00859-1 ↗
36. 10.1038/s41577-019-0127-610.1038/s41577-019-0127-6 ↗
37. 10.1016/j.immuni.2023.08.01410.1016/j.immuni.2023.08.014 ↗
38. 10.1038/s41467-020-17750-z10.1038/s41467-020-17750-z ↗
39. 10.1136/jitc-2019-00020710.1136/jitc-2019-000207 ↗